News

New C3 Complement Mechanism Identified in Atherosclerosis Progression

Researchers from the Biomarkers of Cardiovascular Disease Progression group at the Institut de Recerca Sant Pau (IR Sant Pau) have identified a new mechanism by which complement C3, a key immune syste...

The Viladecans Cancer Coordinator Association supports CADASIL research with a donation to IR Sant Pau

The Sant Pau Research Institute (IR Sant Pau) has received a donation of 2,500 euros from the Viladecans Cancer Coordinator Association, aimed at boosting the research conducted by the centre on CADAS...

Sant Pau Research Institute Strengthens Its European Leadership With New National Funding to Reinforce Its Internationalization Structure

The Sant Pau Research Institute (IR Sant Pau) has received new national funding from the Spanish State Research Agency (AEI), an agency under the Ministry of Science, Innovation, and Universities. Thi...

Sant Pau Hosts the First National GEICEN Meeting on Gynecologic Cancer

Hospital de Sant Pau recently hosted the First National Meeting of the GEICEN Group (Stable Research Group in Gynecologic Cancer), a gathering that brought together researchers and specialists from ac...

The Combination of Carvedilol and Simvastatin Improves Portal Hypertension Control and Inflammatory Markers in Patients with Cirrhosis

Researchers from the Sant Pau Research Institute (IR Sant Pau) have conducted a clinical trial demonstrating that the combination of two widely available drugs, carvedilol and simvastatin, significant...